top of page
News
Search
All Posts
3R Pharma Ltd. Announces the Appointment of Prof. Boris Knaizer to its Scientific Advisory Board
June 22, 2023 – Yeruham, Israel: 3R Pharma Ltd., a preclinical-stage pharmaceutical company focused on developing novel cannabinoid-based...
Michael Rubinov
May 212 min read
Â
Â
Â
3R Pharma Ltd. Announces the Appointment of Prof. Avi Solomon to its Scientific Advisory Board
2.23.2023, Yeruham, Israel - 3R Pharma Ltd, a preclinical-stage pharmaceutical company-up focused on developing novel cannabinoid-based...
Michael Rubinov
May 212 min read
Â
Â
Â
3R Pharma Receives Follow-On Investment from The Israeli Innovation Authority and CanNegev Incubator to Accelerate Cannabinoids-based Ophthalmic Drug Development
[19.02.2023 Yeruham, Israel] - 3R Pharma Ltd, a preclinical pharmaceutical company focused on developing novel cannabinoid-based...
Michael Rubinov
May 212 min read
Â
Â
Â
3R Pharma announces seed investment
We have partnered with CanNegev Incubator that was established as a joint venture of Perrigo/Padagis, BOL Pharma, OurCrowd, and Israeli...
Michael Rubinov
May 51 min read
Â
Â
Â
bottom of page